Combination of Ad-SGE-REIC and bevacizumab modulates glioma progression by suppressing tumor invasion and angiogenesis.
Hattori Y, Kurozumi K, Otani Y, Uneda A, Tsuboi N, Makino K, Hirano S, Fujii K, Tomita Y, Oka T, Matsumoto Y, Shimazu Y, Michiue H, Kumon H, Date I.
Hattori Y, et al. Among authors: date i.
PLoS One. 2022 Aug 25;17(8):e0273242. doi: 10.1371/journal.pone.0273242. eCollection 2022.
PLoS One. 2022.
PMID: 36006934
Free PMC article.